- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01908946
Automated SMS Reminders to Parents on Their Cell Phones Can Significantly Improve the on Time Vaccination Rates Children in Pakistan
July 24, 2013 updated by: Dr Abdul Momin Kazi, Aga Khan University
Automated SMS Reminders to Parents on Their Cell Phones Can Significantly Improve the on Time Vaccination Rates Among Children in Pakistan
The investigators plan to test the effectiveness of reminders to parents/guardians on cell phones through short messaging system (SMS) in improving the on-time routine immunization for children in Pakistan.
SMS message as a reminder tool can be very effective in health care settings at public health scale.
This study will be conducted in an urban- squatter settlement area, Ibrahim Haidry union council in Karachi.
Parents/guardians of children randomized in intervention arm will be sent SMS reminders vaccination visit reminders at 6, 10 and 14 weeks of life.
Study Overview
Detailed Description
The immunization coverage in Pakistan is still well below the desired level, leading to continued polio transmission, large measles outbreaks and thousands of deaths from vaccine-preventable illnesses.
A major reason for poor childhood vaccine coverage is the lack of awareness among parents regarding the need for immunization in children, and the importance of completing the entire series of vaccines.
This result in significant drop-out between vaccines delivered at birth and later in the infancy period.
Customized short messaging system (SMS) text can be designed as personally tailored messages to remind and inquire parents regarding vaccination for their children according to the EPI schedule.
We plan to test the effectiveness of reminders to parents/guardians on cell phones through short messaging system (SMS) in improving the on-time routine immunization for children in Pakistan.
This study will be conducted in an urban- squatter settlement area, Ibrahim Haidry union council in Karachi, Pakistan.
Our experimental plan has three components: First, we will conduct baseline survey of parents at our study site to explore their preferences for text for immunization reminders.
Simultaneously, we will develop a computerized application for reminders scheduling.
This application will contain the phone number, message information, language preferences and date on which the message will be sent.
It will be interfaced with the gateway to send the message.
Lastly, we will conduct a randomized controlled trial to determine the effectiveness of automated SMS reminders to parents in improving the on-time vaccination rates in children.
If the result shows that the vaccines compliance can be increased through the SMS reminders, this program can be incorporated with the existing systems to collect the cell phone numbers of parents at the time of child's first contact with the health system and sending auto generated reminders for vaccine compliance at national level.
Study Type
Interventional
Enrollment (Anticipated)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sindh
-
Karachi, Sindh, Pakistan, 74800
- Recruiting
- Aga Khan University
-
Contact:
- Abdul M Kazi, MBBs,MPH
- Phone Number: +92 21 34864335
- Email: momin.kazi@aku.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 2 weeks (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Child should be less than 14 days of age
- Parent/guardian or at least one person in the household having a valid cell phone connection
- Parent/guardian provides consent
Exclusion Criteria:
- Child more than 14 days of age
- Not a valid cell phone connection in the household
- Parent/guardian not providing consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: SMS Reminders
SMS reminders
|
SMS reminders for vaccination visit at 6, 10 and 14 weeks of life.
|
|
No Intervention: Standard verbal counseling
One time standard verbal counseling at the time of initial visit and timing for EPI vaccines at 6, 10 and 14 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Improvement in the vaccination coverage due to SMS reminders
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Ibrahim M Abdel Rahim, MBBS, Ibrahim Mohamed ABDEL RAHIM
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2013
Primary Completion (Anticipated)
October 1, 2013
Study Completion (Anticipated)
October 1, 2013
Study Registration Dates
First Submitted
July 15, 2013
First Submitted That Met QC Criteria
July 24, 2013
First Posted (Estimate)
July 26, 2013
Study Record Updates
Last Update Posted (Estimate)
July 26, 2013
Last Update Submitted That Met QC Criteria
July 24, 2013
Last Verified
July 1, 2013
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- EM-2013-IER-RPC-TSA-008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vaccination Failure
-
University of Roma La SapienzaCompletedVaccination Failure | Vaccination Adverse Events | Specific Antibody ResponseItaly
-
Lifespan Healthcare Resource LimitedBill and Melinda Gates FoundationUnknown
-
Aga Khan UniversityWorld Health OrganizationUnknownVaccination FailurePakistan
-
Centre Hospitalier Universitaire de NiceCompletedVaccination Failure
-
University of AlbertaMerck Canada Inc.RecruitingVaccine Response Impaired | Vaccination FailureCanada
-
University of Massachusetts, WorcesterRecruiting
-
University of TorontoWholehealth Pharmacy PartnersNot yet recruitingVaccination | Vaccination Reaction | Vaccination Pain | Vaccination PharmacyCanada
-
University of IowaNational Institute on Aging (NIA)CompletedVaccination | Vaccination Hesitancy | Vaccination Promotion | Psychological AspectsUnited States
-
Xiamen UniversityXiamen Center for Disease Control and PreventionNot yet recruitingHPV Vaccination Rates | HPV Vaccine Awareness | HPV Vaccination Intention
-
University of PennsylvaniaCompletedVaccine Refusal | Vaccination Hesitancy | Human Papillomavirus VaccinationUnited States
Clinical Trials on SMS reminders
-
Massachusetts General HospitalUniversity of Washington; Kenya Medical Research InstituteCompleted
-
Absolute Return for KidsUnited States Agency for International Development (USAID); Department for... and other collaboratorsCompleted
-
Societe Francaise de RhumatologieAssistance Publique - Hôpitaux de Paris; University Hospital, ToulouseCompletedRheumatoid ArthritisFrance
-
SKEZIInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'EnvironnementCompletedGeneral Population (no Specific Condition or Disease)France
-
University of the PhilippinesDepartment of Health, PhilippinesCompletedHypertensionPhilippines
-
Northwestern UniversityMerck Sharp & Dohme LLCCompletedType 2 DiabetesUnited States
-
University of MalayaCompletedPhysical Activity | ExerciseMalaysia
-
Mbarara University of Science and TechnologyMassachusetts General Hospital; National Institutes of Health (NIH)Unknown
-
Emory UniversityCompletedSurgical Site InfectionUnited States